Treatment satisfaction among patients with psoriasis in Saudi Arabia
https://doi.org/10.4081/dr.2024.9967
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Psoriasis, affecting 2% of the population, burdens individuals physically and emotionally, with adherence challenges (39–73%). Treatment ranges from topical to systemic therapy including biologics. Although biologic therapy improves clinical outcomes, side effects lead 50% of severe cases to prefer topical treatment. This study evaluates patient satisfaction in Saudi Arabia with various psoriasis treatments, offering insights and addressing the crucial aspect of satisfaction in management. This is a cross-sectional study, using an electronic questionnaire aligned with prior research, included Saudi adults with psoriasis undergoing topical, biological, or phototherapy treatment. Exclusions encompassed non-treatment recipients and participants outside Saudi Arabia. A total of 314 psoriasis patients receiving treatment were included, the most reported types were Plaque psoriasis. The most reported sites of psoriasis included scalp. 70.1% of the patients received topical treatment, 36.3% received systematic treatment, and 18.2% used phototherapy. The participants showed an intermediate satisfaction level, the highest satisfaction for systematic treatments followed by phototherapy and the lowest satisfaction for topical treatments. Male gender, plaque psoriasis, and lack of disease follow-up were associated with poor satisfaction levels.
Kim N, Thrash B, Menter A. Comorbidities in psoriasis patients. Semin Cutan Med Surg. 2010;29:10–5. DOI: https://doi.org/10.1016/j.sder.2010.01.002
Zhang M, Brenneman S, Carter C, et al. Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis. Patient Prefer Adherence. 2015;9:777. DOI: https://doi.org/10.2147/PPA.S85773
van Cranenburgh OD, de Korte J, Sprangers MAG,et al. Satisfaction with treatment among patients with psoriasis: a web-based survey study. Br J Dermatol. 2013;169:398–405. DOI: https://doi.org/10.1111/bjd.12372
Finch T, Shim T, Roberts L, Johnson O. Treatment satisfaction among patients with moderate-to-severe psoriasis. J Clin Aesthet Dermatol. 2015;8:26–30.
Kim W, Jerome D, Yeung J. Diagnosis and management of psoriasis. Canadian family physician Medecin de famille canadien. 2017;63:278–85.
Damiani G, Pacifico A, Chu S, Chi C-C, Young Dermatologists Italian Network (YDIN). Frequency of phototherapy for treating psoriasis: a systematic review. Ital J Dermatol Venerol. 2022;157:215-9 DOI: https://doi.org/10.23736/S2784-8671.21.06975-3
Fernández-Guarino M, Aboín-González S, Velázquez D,et al. Phototherapy with narrow-band UVB in adult guttate psoriasis: Results and patient assessment. Dermatology. 2016;232:626–32. DOI: https://doi.org/10.1159/000448918
Teeple A, Villacorta R, PharmD SL,et al. Determinants of patient and physician treatment satisfaction in moderate-to-severe psoriasis: a multinational survey of psoriasis patients. Dermatol Online J [Internet]. 2021;27. DOI: https://doi.org/10.5070/D3271055618
Armstrong AW, Robertson AD, Wu J,et al. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: Findings from the national psoriasis foundation survey. 2013;149:1180. DOI: https://doi.org/10.1001/jamadermatol.2013.5264
Florek AG, Wang CJ, Armstrong AW. Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review. Arch Derm Res. 2018;310:271–319. DOI: https://doi.org/10.1007/s00403-018-1808-x
Dubertret L, Mrowietz U, Ranki A,et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey: EUROPSO patient quality of life survey. Br J Dermatol. 2006;155:729–36. DOI: https://doi.org/10.1111/j.1365-2133.2006.07405.x
Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137:280–4.
Franzke N, Montenbruck M, Langenbruch AK,et al. Drug supply for psoriasis – results from a national pharmacy network. J Dtsch Dermatol Ges. 2013;11:638–43. DOI: https://doi.org/10.1111/j.1610-0387.2012.08071.x
Poulin Y, Papp KA, Wasel NR, et al. A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis. Int J Dermatol. 2010;49:1368–75. DOI: https://doi.org/10.1111/j.1365-4632.2010.04660.x
Radtke MA, Spehr C, Reich K,et al. Treatment satisfaction in psoriasis: Development and use of the PsoSat patient questionnaire in a cross-sectional study. Dermatology. 2016;232:334–43. DOI: https://doi.org/10.1159/000444635
Ragnarson Tennvall G, Hjortsberg C, Bergman A, et al. Are treatment satisfaction, quality of life, and self-assessed disease severity relevant parameters for patient registries? Experiences from Finnish and Swedish patients with psoriasis. Acta Derm Venereol. 2011;91:409–14. DOI: https://doi.org/10.2340/00015555-1094
Schaarschmidt M, Kromer C, Herr R, et al. Treatment satisfaction of patients with psoriasis. Acta Derm Venereol. 2015;95:572–8. DOI: https://doi.org/10.2340/00015555-2011
Callis Duffin K, Yeung H, Takeshita J, et al. Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. Br J Dermatol. 2014;170:672–80. DOI: https://doi.org/10.1111/bjd.12745
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
